{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:13:41Z","timestamp":1791101621514,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.nmd.2005.07.005","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T14:23:10Z","timestamp":1128435790000},"page":"802-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy11\u201313 February 2005Naarden, The Netherlands"],"prefix":"10.1016","volume":"15","author":[{"given":"E.","family":"Bertini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Burghes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Estournet-Mathiaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.C.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Voit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Reitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tizzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zerres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2005.07.005_bib1","doi-asserted-by":"crossref","unstructured":"Crawford TO. Concerns about the design of clinical trials for spinal muscular atrophy. Neuromuscul Disord 2004;14: 456\u201360. Review.","DOI":"10.1016\/j.nmd.2004.04.004"},{"key":"10.1016\/j.nmd.2005.07.005_bib2","first-page":"63","volume":"19","author":"Lorson","year":"1998","journal-title":"SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","article-title":"Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1","volume":"114","author":"Helmken","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib5","doi-asserted-by":"crossref","unstructured":"Lorson CL, Androphy EJ. 2000. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 9:259-265.","DOI":"10.1093\/hmg\/9.2.259"},{"key":"10.1016\/j.nmd.2005.07.005_bib6","first-page":"93","volume":"11","author":"Monani","year":"2002","journal-title":"Sendtner M, Coovert DD, et al. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp\/hnRNP-Q: a role for Smn in RNA processing in motor axons? Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/10.5.497","article-title":"Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy","volume":"10","author":"Jablonka","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib8","first-page":"1605","volume":"11","author":"Fan","year":"2002","journal-title":"Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib9","first-page":"6627","volume":"23","author":"Zhang","year":"2003","journal-title":"Active transport of the survival motor neuron (SMN) protein and the role of exon-7 in cytoplasmic localization. J Neurosci"},{"key":"10.1016\/j.nmd.2005.07.005_bib10","first-page":"66","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"A mouse model for spinal muscular atrophy. Nat Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib11","first-page":"333","volume":"9","author":"Monani","year":"2000","journal-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib12","first-page":"957","volume":"6","author":"Baron-Delage","year":"2000","journal-title":"Abadie A, Echaniz-Laguna A, Melki J, Beretta L. Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes. Mol Med"},{"key":"10.1016\/j.nmd.2005.07.005_bib13","first-page":"2841","volume":"10","author":"Andreassi","year":"2001","journal-title":"Jarecki J, Zhou DD, et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib14","first-page":"9808","volume":"98","author":"Chang","year":"2001","journal-title":"Li H. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2005.07.005_bib15","first-page":"1532","volume":"8","author":"Zhang","year":"2001","journal-title":"Zhou J. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther"},{"key":"10.1016\/j.nmd.2005.07.005_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2005.07.005_bib17","doi-asserted-by":"crossref","unstructured":"Le TT, Pham LT, Butchbach ME, et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 2005; 14: 845-57.","DOI":"10.1093\/hmg\/ddi078"},{"key":"10.1016\/j.nmd.2005.07.005_bib18","first-page":"27","volume":"23","author":"Butchbach","year":"2004","journal-title":"Le TT, Burghes AHM. Protective effects of butyrate analoguesand prodrugs on a mouse model for spinal muscular atrophy. Abstract 226.17 Neuroscience meeting, S. Diego, USA October"},{"key":"10.1016\/j.nmd.2005.07.005_bib19","first-page":"1726","volume":"114","author":"Azzouz","year":"2004","journal-title":"Le T, Ralph GS, et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest"},{"key":"10.1016\/j.nmd.2005.07.005_bib20","first-page":"377","volume":"30","author":"Cartegni","year":"2002","journal-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 Nat Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","article-title":"Evidence for a modifying pathway in SMA discordant families: Reduced SMN levels decreases the amount of its interacting partners and of Htra2-beta1","volume":"114","author":"Helmken","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib22","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/hmg\/11.12.1439","article-title":"Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model","volume":"11","author":"Cifuentes-Diaz","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-8993(97)00144-3","article-title":"Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury","volume":"756","author":"Wahl","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.nmd.2005.07.005_bib28","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2005.07.005_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.10455","article-title":"Riluzole attenuates spinal muscular atrophy disease progression in a mouse model","volume":"28","author":"Haddad","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.07.005_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","article-title":"Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy","volume":"12","author":"Lesbordes","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2005.07.005_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1083\/jcb.200210117","article-title":"Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle","volume":"161","author":"Nicole","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2005.07.005_bib32","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/brain\/awf155","article-title":"Neuronal death is enhanced and begins during fetal development in type I spinal muscular atrophy spinal cord","volume":"125","author":"Soler-Botija","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2005.07.005_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-002-0566-0","article-title":"Motor neuron death in normal and spinal muscular atrophy-affected human fetuses","volume":"104","author":"Fidzianska","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2005.07.005_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnen\/62.4.420","article-title":"Downregulation of Bcl-2 proteins in type I SMA motor neurons during fetal development","volume":"62","author":"Soler-Botija","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib35","first-page":"253","volume":"15","author":"Soler-Botija","year":"2005","journal-title":"Choline acetyltransferase expression does not identify early pathogenic events in fetal SMA spinal cord Neuromusc Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib36","first-page":"215","volume":"64","author":"Soler-Botija","year":"2005","journal-title":"Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function? J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.47.4.973","article-title":"Function changes in spinal muscular atrophy II and III","volume":"47","author":"Russman","year":"1996","journal-title":"The DCN\/SMA Group. Neurology"},{"key":"10.1016\/j.nmd.2005.07.005_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.60.11.1601","article-title":"A phase 1 trial of riluzole in spinal muscular atrophy","volume":"60","author":"Russman","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib39","first-page":"127","volume":"191","author":"Miller","year":"2001","journal-title":"A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci"},{"key":"10.1016\/j.nmd.2005.07.005_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/08830738030180080501","article-title":"Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study","volume":"18","author":"Merlini","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation","volume":"7","author":"Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib43","first-page":"1130","article-title":"AmSMART Group","volume":"60","author":"Iannacone","year":"2003","journal-title":"Reliability of 4 outcome measures in pediatric spinal muscular atrophy. Arch Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ppul.10110","article-title":"Spinal muscular atrophy type 1: management and outcomes","volume":"34","author":"Bach","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2005.07.005_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.nmd.2004.09.004","article-title":"Sleep disordered breathing in spinal muscular atrophy","volume":"14","author":"Mellies","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1378\/chest.126.3.831","article-title":"Respiratory capacity course in patients with infantile spinal muscular atrophy","volume":"126","author":"Ioos","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.nmd.2005.07.005_bib47","unstructured":"Finkel RS, B\u00f6nnemann CG, Weinerb DJ, et al. Defining outcome measures for clinical trials in spinal muscular atrophy, type 1. Neuromuscul Disord 2004;14:596:Abst. T.P.2.03."},{"key":"10.1016\/j.nmd.2005.07.005_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.10050","article-title":"Motor unit number estimation in infants and children with spinal muscular atrophy","volume":"25","author":"Bromberg","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.07.005_bib49","first-page":"1445","article-title":"AmSMART Group","volume":"59","author":"Iannacone","year":"2002","journal-title":"Outcome measures for pediatric spinal muscular atrophy. Arch Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib50","doi-asserted-by":"crossref","unstructured":"Finder JD, Birnkrant D, Carl J, et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456\u201365. Review.","DOI":"10.1164\/rccm.200307-885ST"},{"key":"10.1016\/j.nmd.2005.07.005_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0960-8966(02)00212-2","article-title":"Muscular dystrophy campaign sponsored workshop: recommendation for respiratory care of children with spinal muscular atrophy type II and III, 13th February 2002, London, UK","volume":"3","author":"Manzur","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib52","first-page":"56","article-title":"Workshop: ventilatory support in congenital neuromuscular disorders\u2014congenital myopathies","volume":"14","author":"Wallgren-Pettersson","year":"2004","journal-title":"Congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4\u20136 April 2003, Naarden, The Netherlands. Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib53","first-page":"423","volume":"2","author":"Munsat","year":"1992","journal-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany). Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2005.07.005_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mus.10166","article-title":"Reliability of hand-held dynamometry in spinal muscular atrophy","volume":"26","author":"Merlini","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.07.005_bib55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mus.20018","article-title":"Motor function-muscle strength relationship in spinal muscular atrophy","volume":"29","author":"Merlini","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2005.07.005_bib56","first-page":"518","article-title":"Natural history in proximal spinal muscular atrophy","volume":"52","author":"Zerres","year":"1995","journal-title":"Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","article-title":"A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients","volume":"146","author":"Zerres","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2005.07.005_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000052118","article-title":"The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III","volume":"45","author":"Rudnik-Schoneborn","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nmd.2005.07.005_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/088307389400900321","article-title":"Pulmonary function in spinal muscular atrophy","volume":"9","author":"Samaha","year":"1994","journal-title":"J Child Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896605002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896605002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:53:58Z","timestamp":1760774038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896605002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0960896605002257"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2005.07.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy11\u201313 February 2005Naarden, The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2005.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}